Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/119366
Campo DC Valoridioma
dc.contributor.authorMartín Rodríguez, Alberto Jonatanen_US
dc.contributor.authorRomling, Uteen_US
dc.date.accessioned2022-11-25T09:53:08Z-
dc.date.available2022-11-25T09:53:08Z-
dc.date.issued2017en_US
dc.identifier.isbn18734294 15680266-
dc.identifier.issn1568-0266en_US
dc.identifier.urihttp://hdl.handle.net/10553/119366-
dc.description.abstractBacterial biofilm formation and associated phenotypes are causative for chronic infection in humans. The major regulators of biofilm formation in Gram-negative and Gram-positive bacteria are nucleotide-based second messenger signaling pathways. Nucleotide-based signaling is a ubiquitous signal transduction mechanism in all domains of life that relay changes in the extracellular or intracellular milieu to protein or RNA effectors, leading to adaptive physiological responses. To date, six bona fide nucleotide signaling pathways, (p)ppGpp, cAMP, cGMP, c-di-AMP, c-di-GMP and cGAMP, have been characterized with respect to basic pathway modules and phenotypic and physiological output. Thereby, c-di-GMP is by far the most complex signaling network with up to over 100 turnover proteins in some bacteria. While c-di-GMP is a ubiquitous regulator of the motility/sessility switch which translates into the transition from acute to chronic infection, and (p)ppGpp has been shown to be required for persistence, the role of other nucleotide signaling pathways is comparatively poorly characterized. Due to their importance in chronic infections, interference with these signal transduction systems has emerged as a strategy for the control of recurrent bacterial infections. Substantial efforts are being placed in finding small molecules for antibiofilm chemotherapy. The purpose of this review is to provide an overview of our current knowledge on bacterial nucleotide signaling and to provide an up-to-date perspective on small molecules thwarting these transduction pathways. Furthermore, we summarize the high-throughput approaches developed for the discovery of small-molecule inhibitors of nucleotide turnover proteins or effectors from large chemical libraries. Implications and future prospects for the control of biofilm-related infections are discussed. We also highlight the current needs and future directions that could lead to a better understanding of these important signaling networks.en_US
dc.languageengen_US
dc.relation.ispartofCurrent Topics in Medicinal Chemistryen_US
dc.sourceCurrent Topics in Medicinal Chemistry [ISSN 1568-0266], v. 17 (17), (2017)en_US
dc.subject.other(p)ppGppen_US
dc.subject.otherBiofilmen_US
dc.subject.otherc-di-GMPen_US
dc.subject.othercAMPen_US
dc.subject.othercGAMPen_US
dc.subject.othercGMPen_US
dc.subject.otherNucleotide signalingen_US
dc.subject.otherSmallolecule inhibitorsen_US
dc.titleNucleotide Second Messenger Signaling as a Target for the Control of Bacterial Biofilm Formationen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.identifier.doi10.2174/1568026617666170105144424en_US
dc.identifier.scopus2-s2.0-85021082094-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.identifier.issue17-
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.external49585782-
dc.utils.revisionen_US
dc.identifier.ulpgcNoen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,885
dc.description.jcr3,374
dc.description.sjrqQ2
dc.description.jcrqQ2
dc.description.scieSCIE
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR Investigación Básica y Aplicada en Ciencias de la Salud-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0003-2422-129X-
crisitem.author.parentorgDepartamento de Ciencias Clínicas-
crisitem.author.fullNameMartín Rodríguez, Alberto Jonatan-
Colección:Artículos
Vista resumida

Visitas

380
actualizado el 31-ago-2024

Descargas

443
actualizado el 31-ago-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.